Hedwig E Deubzer Selected Research

Hedwig E Deubzer Research Topics

Disease

32	Neuroblastoma 04/2022 - 04/2008
29	Neoplasms (Cancer) 01/2022 - 04/2008
6	Medulloblastoma 01/2019 - 06/2010
4	Disease Progression 01/2021 - 03/2009
3	Ependymoma 11/2012 - 03/2009
2	Hemorrhage 01/2022 - 10/2020
2	Neoplasm Metastasis (Metastasis) 01/2020 - 03/2009
2	Carcinoma (Carcinomatosis) 05/2013 - 07/2008
2	Retinoblastoma (Glioblastoma, Retinal) 06/2008 - 04/2008
1	Thrombosis (Thrombus) 01/2022
1	Fibrosarcoma 01/2022
1	Hemophilia B (Haemophilia B) 01/2022
1	Hemophilia A (Haemophilia) 01/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 06/2021
1	Pain (Aches) 01/2021
1	Fever (Fevers) 01/2021
1	Hyperemia 01/2021
1	Superinfection 01/2021
1	Starvation 01/2021
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 10/2020
1	Brain Neoplasms (Brain Tumor) 04/2017
1	Isochromosomes 12/2012
1	Osteosarcoma (Osteogenic Sarcoma) 09/2010
1	Infections 09/2010
1	Sarcoma (Soft Tissue Sarcoma) 09/2010
1	Rhabdomyosarcoma 09/2010
1	Chromosome Aberrations (Chromosome Abnormalities) 03/2009

Drug/Important Bio-Agent (IBA)

11	Pharmaceutical PreparationsIBA 12/2021 - 01/2009
11	Histone Deacetylase InhibitorsIBA 12/2021 - 04/2008
10	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2008
5	Histone Deacetylases (Histone Deacetylase)IBA 01/2017 - 01/2009
4	Cell-Free Nucleic AcidsIBA 04/2022 - 10/2017
4	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 03/2009
3	NucleotidesIBA 07/2021 - 01/2020
3	Chimeric Antigen ReceptorsIBA 01/2021 - 01/2020
3	Small Interfering RNA (siRNA)IBA 07/2012 - 11/2008
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2021 - 01/2021
2	Phosphoglycerate Dehydrogenase (Dehydrogenase, Phosphoglycerate)IBA 12/2021 - 01/2021
2	Messenger RNA (mRNA)IBA 07/2012 - 01/2009
2	Vorinostat FDA Link 11/2011 - 09/2010
2	HC toxinIBA 06/2008 - 04/2008
1	Circulating Tumor DNAIBA 01/2022
1	Hemostatics (Antihemorrhagics)IBA 01/2022
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 01/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022
1	Phosphopyruvate Hydratase (Enolase)IBA 01/2022
1	NucleosidesIBA 12/2021
1	Anaplastic Lymphoma KinaseIBA 12/2021
1	PanobinostatIBA 12/2021
1	NCT-503IBA 12/2021
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 01/2021
1	dinutuximabIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Dipyrone (Metamizole)IBA 01/2021
1	SuspensionsIBA 01/2021
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2021
1	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 01/2021
1	ProteomeIBA 01/2021
1	Serine (L-Serine)FDA Link 01/2021
1	Busulfan (Busulfex)FDA Link 10/2020
1	Tranexamic Acid (AMCA)FDA Link 10/2020
1	Melphalan (Alkeran)FDA LinkGeneric 10/2020
1	LuciferasesIBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	CytokinesIBA 01/2020
1	AntigensIBA 01/2020
1	tyrosine receptor (receptor, tyrosine)IBA 01/2020
1	NivolumabIBA 01/2020
1	BI 6727IBA 01/2019
1	Tumor Suppressor Protein p53IBA 04/2017
1	Adenosine Triphosphate (ATP)IBA 01/2017
1	Polo-Like Kinase 1IBA 01/2017
1	GSK 461364IBA 01/2017
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2017
1	BI 2536IBA 01/2017
1	Biological ProductsIBA 01/2017
1	MethyltransferasesIBA 10/2016
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 10/2016
1	Histone Deacetylase 2IBA 04/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2013
1	IsoenzymesIBA 07/2013
1	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 07/2013
1	Cytotoxins (Cytolysins)IBA 07/2013
1	MicroRNAs (MicroRNA)IBA 07/2013
1	ZincIBA 05/2013
1	Glial Fibrillary Acidic ProteinIBA 12/2012
1	NestinIBA 11/2012
1	Oncogene Proteins (Oncogene Protein)IBA 07/2012
1	nutlin 3IBA 07/2012
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 06/2010

Therapy/Procedure

21	Therapeutics 01/2022 - 04/2008
6	Drug Therapy (Chemotherapy) 01/2022 - 11/2011
2	Stem Cell Transplantation 01/2022 - 01/2021
2	Transplantation 12/2012 - 11/2011
1	Fluid Therapy (Oral Rehydration Therapy) 01/2021
1	Analgesia 01/2021
1	Hematopoietic Stem Cell Transplantation 10/2020
1	Investigational Therapies (Experimental Therapy) 01/2020
1	Combined Modality Therapy 10/2016
1	Oncolytic Virotherapy 09/2010